| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0086 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |